SlideShare a Scribd company logo
See	discussions,	stats,	and	author	profiles	for	this	publication	at:	https://www.researchgate.net/publication/229455808
REVIEW	OF	THE	BASIC	COMPONENTS	OF
CLINICAL	PHARMACEUTICAL	CARE	IN
PAKISTAN
ARTICLE	·	MARCH	2011
READS
224
3	AUTHORS,	INCLUDING:
Taha	Nazir
University	of	Lahore
41	PUBLICATIONS			29	CITATIONS			
SEE	PROFILE
All	in-text	references	underlined	in	blue	are	linked	to	publications	on	ResearchGate,
letting	you	access	and	read	them	immediately.
Available	from:	Taha	Nazir
Retrieved	on:	21	March	2016
T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011
1 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969,
Fax: 924237117012
Review Article
REVIEW OF THE BASIC COMPONENTS OF CLINICAL PHARMACEUTICAL CARE
IN PAKISTAN
Taha Nazir, Syed Muzzammil Masood Zaidi
School of Pharmacy, The University of Lahore, Islamabad Campus, 24-West, Jinnah Avenue, Blue Area,
Islamabad, Pakistan.
ABSTRACT
Poor clinical pharmaceutical system in developing part of the world is big health hurdle. That
also is a major reason of drug interactions, wrong medications, clinical errors, medical
mistakes and therapeutical complications. We have aimed to uplift the health standards to
mitigate drug abuse, enhance rational prescriptions and minimize the causalities. While going
through the pharmaceutical care, we can’t ignore the channel through which the drugs
supplied without proper check i.e. bio-safety, therapeutical monitoring, medication review etc.
Moreover; something is missing in between the physician and patient to make sure the
correct medication. The medial practice needs more legal and principled restrictions to
assure the safe and correct therapy plans. The clinical legislation and drug rules of health
practice seriously need the attention of judiciary, society and leadership to assure the safety
of precious human live.
Key words: clinical services, pharmaceutical care, primary health care, tertiary health care
Corresponding Address: Dr. Taha Nazir, Associate Dean, School of Pharmacy, The
University of Lahore, Islamabad Campus, 24-West, Jinnah Avenue, Blue Area, Islamabad,
Pakistan. Cell: +92 321 222 0885, Tel.: 051-282 9162-64, Fax: 051-282 9238, Email:
tahanazir@yahoo.com, www.uol.edu.pk
There are eight (8) basic components of clinical pharmacy practice; Prescribing drugs, Administering
drugs, Documenting professional services, Reviewing drug use, Communication, Counseling, Consulting
and Preventing Medication Errors (Betty, 2010). While the scope of clinical pharmacy comprised of: Drug
Information, Drug Utilization, Drug Evaluation and Selection, Medication Therapy Management, Formal
Education and Training Program, Disease State Management and Application of Electronic Data
Processing (EDP). The major segments of this discipline are; pharamcovigilance, pharmaco-economics,
therapeutical monitoring, bio-safety, drug informations, and aseptic dispensary.
Health care providers are negligent if they fail to provide the standard of care that a reasonable expert
supposed to give in similar circumstances. If the negligence causes injuries or illness, then the health
care provider is liable. There is no excuse to say: “I did my best, I just didn’t know any better”. If he know
better, he is liable. If the doctor is clearly wrong, patient can sue for malpractice (CBA, 2010). Healthcare
professionals are required to stay current in their knowledge of treatment methods and to meet a
reasonable standard of care. According to medical malpractice law doctors have a duty to conduct their
practice in accordance with the conduct of a prudent and diligent physician in the same circumstances
(Medical Malpractice, 2010). Standards and regulations for medical malpractice vary by country and
jurisdiction within countries. Medical professionals are required to maintain professional liability insurance
T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011
2 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969,
Fax: 924237117012
to offset the risk and costs of lawsuits based on local medical malpractice (The Four Elements of Medical
Malpractice, (1997).
World Health System Resources; Number of physicians and pharmacists vs population and
hospital beds
Country Physician Pharmaceutical personnel Hospital
beds
A
Number Density
A
Number Density
A
Pakistan 126 350 8 8 102 <1 12
Bangladesh 42 881 3 9 411 <1 3
Bosnia and Herzegovina 5 540 14 308 <1 30
Fiji 380 5 90 1 21
Malaysia 17 020 7 2 880 1 19
Mexico 195 897 20 3 189 <1 10
Nepal 5 384 2 358 <1 2
Romania 41 455 19 901 <1 65
Russian Federation 614 183 43 11 521 <1 <1 97
Sri Lanka 10 479 6 990 <1 29
Sudan 11 083 3 1 531 <1 7
Swaziland 171 2 70 <1
Syrian Arab Republic 10 342 5 89 <1 14
United States of America 730 801 26 249 642 9 39
United Kingdom 133 641 23i 29 726 5 32
Yemen 44 960 6 24 080 3 39
Zambia 1 264 1 1 039 1 32
Global 8 413 147 13 2 338950 4 30
A
per 10 000 Population (WHO, 2011)
< Less than
Thus; we have aimed to point out the professional negligencies usually committed in developing countries.
It’s not unenthusiastic critics, professional revenge or commercially biased outlook but an optimistic
manuscript to encourage the implementation of standard clinical regulations in the developing parts of the
world. We also have tried to interpret the professional aspects of therapeutical care and clinical services
to steer clear the reasons of malpractice. We wish to establish a “check” through medication supplied for
patient use. Therapeutical drug monitoring, bio-safety, prescription reviewing, clinical evaluation and
pharmaceutical services carry their meanings in medical and pharmaceutical sciences. Definitely; we are
missing someone important in between the physician and patient if we are not successful to correct
medication usage.
In another way, the serious outcomes clinical discrepancies insist us to explain the clinical issues and
scientific reasons, permissible apprehension and professional concerns. The therapeutical requirements
T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011
3 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969,
Fax: 924237117012
are not been fulfilled throughout the Pakistan (with the exception of Shaukat Khanum Cancer Hospital &
Research Centre and Agha Khan Hospital). Scientifically the prescription is considered as health-care
program to implement and governs the plan of care for an individual patient (Belknap et. al., 2008). The
procedure of prescription and dispensing is used to avoid ambiguities or misinterpretation in clinical
practice (Teichman & Caffee, 2002). The probability of wrong medication can be reduced if the
prescription are be reviewed properly, the clinical plan evaluated correctly and pharmaceutical services
provided with all of their formalities. Particularly, the drugs are not in control of qualified pharmacists. The
community pharmacy practice does not follow the proper procedure. The information of patient, physician
and drugs not properly collected and maintained during dispensing process. Especially the patient’s data
i.e. medical history, social background, personal profile etc is much important to understand and
manipulate to assure rational drug usage.
Health Facilities in Pakistan 2006-07
Type Number
Hospitals 965
Dispensaries 4,916
Basic Health Units 4,872
Rural Health Centers 595
Maternity care hospitals 1,138
TB Centers 371
First Aid Centers 1,080
Beds in hospitals & dispensaries 105,005
Population ion per bed 1,515
Population to health facility ratio 11,413
Source; Ministry of Health
Utilization of Health Facilities of public and private sectors 2004-05
Type In percent
Overall Rural Urban
Private sector (total) 77.25 75.48 79.02
Dispensaries/; hospital 67.91 64.31 71.50
Hakeem/ Herbalist 2.04 2.32 1.76
Homeopathic 1.07 0.60 1.54
Chemist/ pharmacy 4.99 6.89 3.10
Siana/ Siani 1.19 1.36 1.01
Public Sector 22.58 24.18 20.99
Dispensary/ hospital 20.57 20.68 20.47
RHC/ BHC 2.01 3.50 0.52
Note: definition used: Number of sick or injured persons who consulted public versus private facilities/ providers
for treatment, expressed as percentage of the total population that fell sick or was injured during the last 2 weeks
before the PSLM interview.
Source: Government of Pakistan, PSLM survey, 2004-05. Federal Bureau of Statistics Division, 2005.
Therapeutic drug monitoring is an effective safety valve in clinical practice. The blood levels of potent
drugs with a narrow therapeutic index are measured periodically to assure the safety of patients life
(Marshall & Bangert, 2008). The health care workers are supposed to provide necessary arrangements of
therapeutical drug monitoring in special cases.
Pharmacovigilance is another useful constraint to minimize the therapeutical complications. It is applied
for the purpose of detection, assessment, understanding and prevention of adverse effects of medicines
(WHO, 2002). ADRs (adverse drug reactions) are the noxious and unintended effects which may occurs
at normal dose used for the prophylaxis, diagnosis or treatment of disease, or for the modification of
physiological function (WHO, 1972).
T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011
4 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969,
Fax: 924237117012
The International Pharmaceutical Federation (2010) has emphasized the six major elements to contribute
to an overall strategic thrust of the board of pharmacy practice in hospital pharmacy section
(http://www.fip.org/hospital_pharmacy). The six elements; the partnership with patients, enhancing
pharmacy practice, better financial models, evidence-based practices, assuring competency and
sufficient workforce are designed with the collaboration of World Health Organization, UNESCO, World
Health Professions Alliance, Regional Pharmaceutical Forums and All other partners (FIP, 2010). They
have a key role to assure the safe clinical therapeutical practice. Disregarding the recommendation of
such international organization by medical staff may become major reason of causalities.
The patient’s critics, complaint, views or resentment are another important feature of therapeutical care.
Which are the expressions of displeasure or grievance (Lee (2010). In the civil law, the complaint is the
formal pleading that starts the lawsuit in the plaintiff sets of facts and makes a claim for damages. Often
the patient complaints correlate positively with malpractice risk. In a study at Vanderbilt University School
of Medicine; the researchers found a strong link between doctors with a high number of patient
complaints and doctors with a high number of risk management events. The communication problems,
humaneness, clinical care, billing, access, and availability are considered as unsolicited complaints while
the adverse reactions, potential liability and actual lawsuits are management events complaints (Lee,
2010).
The government officials, society and judiciary should have to consider the pharmaceutical services, drug
rules, therapeutical drug monitoring, phramcovigilance, prescription review and clinical evaluation. The
clinical setup of hospital pharmacy of third world countries need the bio-safety, drug informations, and
aseptic dispensary as accomplished in the developed part of the world. We must have to build up
awareness about the pharmaceutical services. We have to place a “check” between the physician and
patient to make sure the correct medication, right dose, proper route in exact time. That will reduce the
casualties occurred every day and everywhere because of the wrong medications. It needs a collective
effort to change the policies, regulations and system to assure the safety of precious live of innocent
patients.
RECOMMENDATIONS
1 Make sure the availability of clinical pharmaceutical services round the clock. The pharmacist
must have to collect the medical, social, personal and professional data of patient to figure out
any possible potential of drug related health hazard.
2 Enforcement of drugs rules to assure the standard drug monitoring system including prescription
review, dose calculation and therapeutical evaluation.
3 Instigation of procedure to uncover the patient’s complaints i.e. suggestion box, patient
satisfaction surveys etc. The patient or guardian should be briefed about the illness, treatment
protocol, and possible outcomes if professional ethics have not any restriction to do so.
4 Implementation of the six major contributing elements of hospital pharmacy section designed by
international pharmaceutical federation (FIP) with the collaboration of World Health Organization,
UNESCO, World Health Professions Alliance, Regional Pharmaceutical Forums and all other
partners (http://www.fip.org/hospital_pharmacy).
5 A process should be developed for handling patient complaints; that will help to create a long-
term effect of reducing malpractice risks. Most patients are willing to forgive occasional
annoyances or disappointments if they perceive that medical professional and the office staff care
about their needs and are trying to satisfy them. Therefore; the verbal, nonwritten policy and
unofficial procedure could help to develop good values and understanding.
6 The physician should keep the patients well treated and happy. They should be vigilant about the
inevitable complaints and how to tackle them. Furthermore; in staff meetings the problems and
complaints should be discussed strictly.
7 Any kind of patient’s letter, phone call, e-mail or text message should be considered and arrange/
invite for free consultation. He should be replied promptly with an expression of taking good care
of his case that will mitigate the grumbles and improve level of satisfaction.
T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011
5 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969,
Fax: 924237117012
8 The patient should be addressed directly in case of clinical grievance. The physicians have to
involve him more seriously to assure the quality of care concerns. The bad result is not
necessarily the result of any human failures/ error.
9 The physician should be investigated for his mistake. Threatens of lawsuit is an excellent reason
of quality services. But he could be helped by insurance coverage. The insurer should be notified.
Notice is a requirement of all policies and it may authorize a quick settlement.
10 The problems related to the irregular visit, nonprofessional behavior, inadequate diagnostic
facilities and non healthy condition in the hospital setting can only be resolved by designing
certain rules and regulations.
11 The conversation with the patient should be documented in the patient's chart. This may later
become evidence of the statue of limitations. At the same time the conversation with insurer or
lawyer should be filed separately to assure the rule of justice.
REFERENCES
1. Belknap SM, Moore H, Lanzotti SA, Yarnold PR, Getz M, et al., (2008). Application of software
design principles and debugging methods to an analgesia prescription reduces risk of severe
injury from medical use of opioids". Clinical Pharmacology & Therapeutics 84 (3): 385–92.
2. Betty H. Dennis (2010). An overview of the clinical pharmacist practitioner in NC. North Carolina
Association of Pharmacists | 109 Church St. | Chapel Hill, NC 27516, Phone: 919.967.2237 |
Fax: 919.968.9430. http://www.ncpharmacists.org/displaycommon.cfm?an=13
3. CBA (2010), The Canadian Bar Association, British Colombia Branch, 10th Floor, 845 Cambie
Street, Vancouver, BC V6B 5T3 http://www.cba.org/bc/public_media/health/420.aspx
4. Lee J. Johnson, Esq (2010), Malpractice Dangers in Patient Complaints, Attorney with Johnson &
Associates, Mt. Kisco, New York, Medscape, LLC, 370 Seventh Avenue, Suite 1101, New York,
NY 10001-3967http://www.medscape.com/viewarticle/725001?src=mp&spon=17&uac=145767CJ
5. Marshall WJ, Bangert SK. (2008) Clinical Chemistry, 6th Edition. Edinburgh, London: Mosby
Elsevier.
6. Medical Malpractice (2010) http://www.lawmedmal.ca/medical_malpractice_law.htm
7. Teichman PG, Caffee AE (2002). "Prescription writing to maximize patient safety" Family Practice
Management 9 (7): 27–30. PMID 12221761. http://www.aafp.org/fpm/2002/0700/p27.pdf.
8. The Four Elements of Medical Malpractice, (1997). Yale New Haven Medical Center: Issues in
Risk Management. 1997. http://info.med.yale.edu/caim/risk/malpractice/malpractice_2.html
9. WHO (2002). The Importance of Pharmacovigilance, World Health Organization, Avenue Appia
20 1211 Geneva 27 Switzerland.

More Related Content

What's hot

Prescription Patterns
Prescription PatternsPrescription Patterns
Prescription Patterns
Hafiz Saad Salman
 
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OFTHE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
Islam Shallal
 
JAPhA Home Based MTM 2016
JAPhA Home Based MTM 2016JAPhA Home Based MTM 2016
JAPhA Home Based MTM 2016
Toni Salvatore
 
Clinical Trials Scenario In India
Clinical Trials Scenario In IndiaClinical Trials Scenario In India
Clinical Trials Scenario In India
Syeelva
 
Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...
Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...
Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...
Healthcare and Medical Sciences
 
Clinical impact of pharmacist presence in icu medical team on mortality rate ...
Clinical impact of pharmacist presence in icu medical team on mortality rate ...Clinical impact of pharmacist presence in icu medical team on mortality rate ...
Clinical impact of pharmacist presence in icu medical team on mortality rate ...
M. Luisetto Pharm.D.Spec. Pharmacology
 

What's hot (20)

Prescription pattern of drugs in pregnancy induced hypertension in a tertiar...
Prescription pattern of drugs in pregnancy induced hypertension  in a tertiar...Prescription pattern of drugs in pregnancy induced hypertension  in a tertiar...
Prescription pattern of drugs in pregnancy induced hypertension in a tertiar...
 
Prescription Patterns
Prescription PatternsPrescription Patterns
Prescription Patterns
 
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OFTHE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
 
Review on impact of clinical pharmacist’s intervention in the prevention of m...
Review on impact of clinical pharmacist’s intervention in the prevention of m...Review on impact of clinical pharmacist’s intervention in the prevention of m...
Review on impact of clinical pharmacist’s intervention in the prevention of m...
 
Thesis_Phd_Effects of clinical pharmacist's interventions
Thesis_Phd_Effects of clinical pharmacist's interventionsThesis_Phd_Effects of clinical pharmacist's interventions
Thesis_Phd_Effects of clinical pharmacist's interventions
 
JAPhA Home Based MTM 2016
JAPhA Home Based MTM 2016JAPhA Home Based MTM 2016
JAPhA Home Based MTM 2016
 
Measurement of medication adherence
Measurement of medication  adherenceMeasurement of medication  adherence
Measurement of medication adherence
 
(DUE) Drug use evaluation
(DUE) Drug use evaluation (DUE) Drug use evaluation
(DUE) Drug use evaluation
 
Clinical Trials Scenario In India
Clinical Trials Scenario In IndiaClinical Trials Scenario In India
Clinical Trials Scenario In India
 
Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...
Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...
Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...
 
Patterns Poster
Patterns PosterPatterns Poster
Patterns Poster
 
Clinical trails overview
 Clinical trails overview Clinical trails overview
Clinical trails overview
 
Study of medication appropriateness during hospital stay and revisits in medi...
Study of medication appropriateness during hospital stay and revisits in medi...Study of medication appropriateness during hospital stay and revisits in medi...
Study of medication appropriateness during hospital stay and revisits in medi...
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
FACTORS ASSOCIATED WITH UNNECESSARY DRUG THERAPY AND INAPPROPRIATE DOSAGE IN ...
 
Medsreconpaper
MedsreconpaperMedsreconpaper
Medsreconpaper
 
Medication errors in pediatric prescriptions
Medication errors in pediatric prescriptionsMedication errors in pediatric prescriptions
Medication errors in pediatric prescriptions
 
Clinical impact of pharmacist presence in icu medical team on mortality rate ...
Clinical impact of pharmacist presence in icu medical team on mortality rate ...Clinical impact of pharmacist presence in icu medical team on mortality rate ...
Clinical impact of pharmacist presence in icu medical team on mortality rate ...
 
Medical Ethics and Negilgence
Medical Ethics and NegilgenceMedical Ethics and Negilgence
Medical Ethics and Negilgence
 
Prescription event monitoring- rumana hameed
Prescription event monitoring- rumana hameedPrescription event monitoring- rumana hameed
Prescription event monitoring- rumana hameed
 

Similar to From trj review of clinical services 2011 review of the basic components of clinical pharmaceutical care in pakistan (2011)taha nazir syed muzzammil ma

So Pyay (571-9661)
So Pyay (571-9661)So Pyay (571-9661)
So Pyay (571-9661)
So Pyay
 
Medication errors and_consequences publication
Medication errors and_consequences publicationMedication errors and_consequences publication
Medication errors and_consequences publication
PARUL UNIVERSITY
 

Similar to From trj review of clinical services 2011 review of the basic components of clinical pharmaceutical care in pakistan (2011)taha nazir syed muzzammil ma (20)

Toc
TocToc
Toc
 
Introduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptxIntroduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptx
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
Prescription Modifying Marketing Factors: A Survey among the Clinicians in Ba...
Prescription Modifying Marketing Factors: A Survey among the Clinicians in Ba...Prescription Modifying Marketing Factors: A Survey among the Clinicians in Ba...
Prescription Modifying Marketing Factors: A Survey among the Clinicians in Ba...
 
A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...
 
PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
 
Pharmacotherapeutics chapter 1 topic 4 STG.pptx
Pharmacotherapeutics chapter 1 topic 4 STG.pptxPharmacotherapeutics chapter 1 topic 4 STG.pptx
Pharmacotherapeutics chapter 1 topic 4 STG.pptx
 
b. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptxb. Clinical Pharmacy.pptx
b. Clinical Pharmacy.pptx
 
challenges of pharmaceutical care-PPT.pptx
challenges of pharmaceutical care-PPT.pptxchallenges of pharmaceutical care-PPT.pptx
challenges of pharmaceutical care-PPT.pptx
 
So Pyay (571-9661)
So Pyay (571-9661)So Pyay (571-9661)
So Pyay (571-9661)
 
Medication errors and_consequences publication
Medication errors and_consequences publicationMedication errors and_consequences publication
Medication errors and_consequences publication
 
EOP.SOJA.S5
EOP.SOJA.S5EOP.SOJA.S5
EOP.SOJA.S5
 
“Intervention of a clinical pharmacist in order to reduce polypharmacy, avera...
“Intervention of a clinical pharmacist in order to reduce polypharmacy, avera...“Intervention of a clinical pharmacist in order to reduce polypharmacy, avera...
“Intervention of a clinical pharmacist in order to reduce polypharmacy, avera...
 
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI... A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
 
Pharmacy and Therapeutic Committee
Pharmacy and Therapeutic CommitteePharmacy and Therapeutic Committee
Pharmacy and Therapeutic Committee
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
research 1
research 1research 1
research 1
 
Drug Bulletin Of Nepal
Drug Bulletin Of Nepal Drug Bulletin Of Nepal
Drug Bulletin Of Nepal
 
CHINESE PHARMACISTS LAW MODIFICATION, HOW TO PROTECT PATIENTS‘INTERESTS?
CHINESE PHARMACISTS LAW MODIFICATION, HOW TO PROTECT PATIENTS‘INTERESTS?CHINESE PHARMACISTS LAW MODIFICATION, HOW TO PROTECT PATIENTS‘INTERESTS?
CHINESE PHARMACISTS LAW MODIFICATION, HOW TO PROTECT PATIENTS‘INTERESTS?
 

More from M. Luisetto Pharm.D.Spec. Pharmacology

pdf-10BOOK MLCF -extended version - MEMBERSHIP- quarta EDIZONE. La gia’ deno...
pdf-10BOOK MLCF -extended version - MEMBERSHIP- quarta  EDIZONE. La gia’ deno...pdf-10BOOK MLCF -extended version - MEMBERSHIP- quarta  EDIZONE. La gia’ deno...
pdf-10BOOK MLCF -extended version - MEMBERSHIP- quarta EDIZONE. La gia’ deno...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Review form MEDWIN OAJPR-EB-24-347 GALENIC LABORATORY INNOVATION ANAD MANAGM...
Review form  MEDWIN OAJPR-EB-24-347 GALENIC LABORATORY INNOVATION ANAD MANAGM...Review form  MEDWIN OAJPR-EB-24-347 GALENIC LABORATORY INNOVATION ANAD MANAGM...
Review form MEDWIN OAJPR-EB-24-347 GALENIC LABORATORY INNOVATION ANAD MANAGM...
M. Luisetto Pharm.D.Spec. Pharmacology
 
La gia’ denominata laurea in Chimica e Farmacia e le competenze del chimico-...
La gia’ denominata laurea in Chimica e Farmacia e le competenze  del chimico-...La gia’ denominata laurea in Chimica e Farmacia e le competenze  del chimico-...
La gia’ denominata laurea in Chimica e Farmacia e le competenze del chimico-...
M. Luisetto Pharm.D.Spec. Pharmacology
 
SETAC MEMBERSHIP 2024-2025 SOCIETY OF ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
SETAC MEMBERSHIP 2024-2025 SOCIETY OF ENVIRONMENTAL  TOXICOLOGY AND CHEMISTRYSETAC MEMBERSHIP 2024-2025 SOCIETY OF ENVIRONMENTAL  TOXICOLOGY AND CHEMISTRY
SETAC MEMBERSHIP 2024-2025 SOCIETY OF ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
M. Luisetto Pharm.D.Spec. Pharmacology
 
Published Book- chimici farmacisti - rassegna normativa- Lulu BOOK STORE 202...
Published Book- chimici farmacisti - rassegna normativa- Lulu BOOK STORE  202...Published Book- chimici farmacisti - rassegna normativa- Lulu BOOK STORE  202...
Published Book- chimici farmacisti - rassegna normativa- Lulu BOOK STORE 202...
M. Luisetto Pharm.D.Spec. Pharmacology
 
2BOOK -laureati in chimica e farmacia- equipollenti ed equiparati -rassegna n...
2BOOK -laureati in chimica e farmacia- equipollenti ed equiparati -rassegna n...2BOOK -laureati in chimica e farmacia- equipollenti ed equiparati -rassegna n...
2BOOK -laureati in chimica e farmacia- equipollenti ed equiparati -rassegna n...
M. Luisetto Pharm.D.Spec. Pharmacology
 
ATTESTATO_ECM- CANNABIS TERAPEUTICA L'INNOVAZIONE DELLA GALENICA luisetto mau...
ATTESTATO_ECM- CANNABIS TERAPEUTICA L'INNOVAZIONE DELLA GALENICA luisetto mau...ATTESTATO_ECM- CANNABIS TERAPEUTICA L'INNOVAZIONE DELLA GALENICA luisetto mau...
ATTESTATO_ECM- CANNABIS TERAPEUTICA L'INNOVAZIONE DELLA GALENICA luisetto mau...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Mauro Luisetto_attesatto WEBINAR 2022 SIFAP GALENICA PREPARATI MULTIPLI QUAL...
Mauro Luisetto_attesatto WEBINAR 2022 SIFAP GALENICA PREPARATI MULTIPLI  QUAL...Mauro Luisetto_attesatto WEBINAR 2022 SIFAP GALENICA PREPARATI MULTIPLI  QUAL...
Mauro Luisetto_attesatto WEBINAR 2022 SIFAP GALENICA PREPARATI MULTIPLI QUAL...
M. Luisetto Pharm.D.Spec. Pharmacology
 
APPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et al
APPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et alAPPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et al
APPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et al
M. Luisetto Pharm.D.Spec. Pharmacology
 
Dott Mauro Luisetto - Attestato sicurezza - ATN FAD - Potenziali effetti sul...
Dott  Mauro Luisetto - Attestato sicurezza - ATN FAD - Potenziali effetti sul...Dott  Mauro Luisetto - Attestato sicurezza - ATN FAD - Potenziali effetti sul...
Dott Mauro Luisetto - Attestato sicurezza - ATN FAD - Potenziali effetti sul...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Ricevuta Quota iscrizione UTIFAR luisetto mauro UNIONE TECNICA ITALIANA FARM...
Ricevuta Quota iscrizione UTIFAR  luisetto mauro UNIONE TECNICA ITALIANA FARM...Ricevuta Quota iscrizione UTIFAR  luisetto mauro UNIONE TECNICA ITALIANA FARM...
Ricevuta Quota iscrizione UTIFAR luisetto mauro UNIONE TECNICA ITALIANA FARM...
M. Luisetto Pharm.D.Spec. Pharmacology
 

More from M. Luisetto Pharm.D.Spec. Pharmacology (20)

pdf-10BOOK MLCF -extended version - MEMBERSHIP- quarta EDIZONE. La gia’ deno...
pdf-10BOOK MLCF -extended version - MEMBERSHIP- quarta  EDIZONE. La gia’ deno...pdf-10BOOK MLCF -extended version - MEMBERSHIP- quarta  EDIZONE. La gia’ deno...
pdf-10BOOK MLCF -extended version - MEMBERSHIP- quarta EDIZONE. La gia’ deno...
 
Review form MEDWIN OAJPR-EB-24-347 GALENIC LABORATORY INNOVATION ANAD MANAGM...
Review form  MEDWIN OAJPR-EB-24-347 GALENIC LABORATORY INNOVATION ANAD MANAGM...Review form  MEDWIN OAJPR-EB-24-347 GALENIC LABORATORY INNOVATION ANAD MANAGM...
Review form MEDWIN OAJPR-EB-24-347 GALENIC LABORATORY INNOVATION ANAD MANAGM...
 
La gia’ denominata laurea in Chimica e Farmacia e le competenze del chimico-...
La gia’ denominata laurea in Chimica e Farmacia e le competenze  del chimico-...La gia’ denominata laurea in Chimica e Farmacia e le competenze  del chimico-...
La gia’ denominata laurea in Chimica e Farmacia e le competenze del chimico-...
 
2 -BOOK -complete version GALENIC- EXTENDED 2 nd edition.pdf
2 -BOOK -complete version GALENIC- EXTENDED 2 nd edition.pdf2 -BOOK -complete version GALENIC- EXTENDED 2 nd edition.pdf
2 -BOOK -complete version GALENIC- EXTENDED 2 nd edition.pdf
 
SETAC MEMBERSHIP 2024-2025 SOCIETY OF ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
SETAC MEMBERSHIP 2024-2025 SOCIETY OF ENVIRONMENTAL  TOXICOLOGY AND CHEMISTRYSETAC MEMBERSHIP 2024-2025 SOCIETY OF ENVIRONMENTAL  TOXICOLOGY AND CHEMISTRY
SETAC MEMBERSHIP 2024-2025 SOCIETY OF ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
 
Chinese chemical Society LUISETTO MAURO 2024-2025 membership.docx
Chinese chemical Society LUISETTO MAURO 2024-2025 membership.docxChinese chemical Society LUISETTO MAURO 2024-2025 membership.docx
Chinese chemical Society LUISETTO MAURO 2024-2025 membership.docx
 
Published Book- chimici farmacisti - rassegna normativa- Lulu BOOK STORE 202...
Published Book- chimici farmacisti - rassegna normativa- Lulu BOOK STORE  202...Published Book- chimici farmacisti - rassegna normativa- Lulu BOOK STORE  202...
Published Book- chimici farmacisti - rassegna normativa- Lulu BOOK STORE 202...
 
RECOGNITION 2024-7 IMA academy official certificate
RECOGNITION 2024-7 IMA academy official certificateRECOGNITION 2024-7 IMA academy official certificate
RECOGNITION 2024-7 IMA academy official certificate
 
2BOOK -laureati in chimica e farmacia- equipollenti ed equiparati -rassegna n...
2BOOK -laureati in chimica e farmacia- equipollenti ed equiparati -rassegna n...2BOOK -laureati in chimica e farmacia- equipollenti ed equiparati -rassegna n...
2BOOK -laureati in chimica e farmacia- equipollenti ed equiparati -rassegna n...
 
REGISTRATION COMMONWEALTH CHEMISTRY LUISETTO MAURO 2024.docx
REGISTRATION COMMONWEALTH CHEMISTRY LUISETTO MAURO 2024.docxREGISTRATION COMMONWEALTH CHEMISTRY LUISETTO MAURO 2024.docx
REGISTRATION COMMONWEALTH CHEMISTRY LUISETTO MAURO 2024.docx
 
PDF SUSCHEM MEMBERSHIP 2024 LUISETTO MAURO SUSTAINABLE CHEMISTRY.pdf
PDF SUSCHEM MEMBERSHIP 2024 LUISETTO MAURO SUSTAINABLE CHEMISTRY.pdfPDF SUSCHEM MEMBERSHIP 2024 LUISETTO MAURO SUSTAINABLE CHEMISTRY.pdf
PDF SUSCHEM MEMBERSHIP 2024 LUISETTO MAURO SUSTAINABLE CHEMISTRY.pdf
 
BOOK MLCF - laurea in chimica e farmacia extended version.pdf
BOOK MLCF - laurea in chimica e farmacia extended version.pdfBOOK MLCF - laurea in chimica e farmacia extended version.pdf
BOOK MLCF - laurea in chimica e farmacia extended version.pdf
 
IJNRDTH00156.pdf galenic laboratory 2024 -innovation and management
IJNRDTH00156.pdf galenic laboratory 2024 -innovation and managementIJNRDTH00156.pdf galenic laboratory 2024 -innovation and management
IJNRDTH00156.pdf galenic laboratory 2024 -innovation and management
 
ATTESTATO_ECM- CANNABIS TERAPEUTICA L'INNOVAZIONE DELLA GALENICA luisetto mau...
ATTESTATO_ECM- CANNABIS TERAPEUTICA L'INNOVAZIONE DELLA GALENICA luisetto mau...ATTESTATO_ECM- CANNABIS TERAPEUTICA L'INNOVAZIONE DELLA GALENICA luisetto mau...
ATTESTATO_ECM- CANNABIS TERAPEUTICA L'INNOVAZIONE DELLA GALENICA luisetto mau...
 
Mauro Luisetto_attesatto WEBINAR 2022 SIFAP GALENICA PREPARATI MULTIPLI QUAL...
Mauro Luisetto_attesatto WEBINAR 2022 SIFAP GALENICA PREPARATI MULTIPLI  QUAL...Mauro Luisetto_attesatto WEBINAR 2022 SIFAP GALENICA PREPARATI MULTIPLI  QUAL...
Mauro Luisetto_attesatto WEBINAR 2022 SIFAP GALENICA PREPARATI MULTIPLI QUAL...
 
APPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et al
APPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et alAPPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et al
APPR.MS.ID.000579.pdf NON STERILE GALENIC LABORATORY 2024 luisetto m et al
 
attestato_6-380924 luisetto mauro IL MEDICINALE MAGISTRALE 2023 (1).pdf
attestato_6-380924 luisetto mauro IL MEDICINALE MAGISTRALE 2023 (1).pdfattestato_6-380924 luisetto mauro IL MEDICINALE MAGISTRALE 2023 (1).pdf
attestato_6-380924 luisetto mauro IL MEDICINALE MAGISTRALE 2023 (1).pdf
 
Dott Mauro Luisetto - Attestato sicurezza - ATN FAD - Potenziali effetti sul...
Dott  Mauro Luisetto - Attestato sicurezza - ATN FAD - Potenziali effetti sul...Dott  Mauro Luisetto - Attestato sicurezza - ATN FAD - Potenziali effetti sul...
Dott Mauro Luisetto - Attestato sicurezza - ATN FAD - Potenziali effetti sul...
 
Ricevuta Quota iscrizione UTIFAR luisetto mauro UNIONE TECNICA ITALIANA FARM...
Ricevuta Quota iscrizione UTIFAR  luisetto mauro UNIONE TECNICA ITALIANA FARM...Ricevuta Quota iscrizione UTIFAR  luisetto mauro UNIONE TECNICA ITALIANA FARM...
Ricevuta Quota iscrizione UTIFAR luisetto mauro UNIONE TECNICA ITALIANA FARM...
 
dott Luisetto MAURO ISCRIZIONE UGI 2024 UNIONE GALENISTI ITALIANI.pdf
dott  Luisetto MAURO ISCRIZIONE UGI 2024 UNIONE GALENISTI ITALIANI.pdfdott  Luisetto MAURO ISCRIZIONE UGI 2024 UNIONE GALENISTI ITALIANI.pdf
dott Luisetto MAURO ISCRIZIONE UGI 2024 UNIONE GALENISTI ITALIANI.pdf
 

Recently uploaded

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 

Recently uploaded (20)

PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptxMALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
MALE REPRODUCTIVE TOXICITY STUDIES(Toxicokinetics).pptx
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptx
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 

From trj review of clinical services 2011 review of the basic components of clinical pharmaceutical care in pakistan (2011)taha nazir syed muzzammil ma

  • 2. T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011 1 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969, Fax: 924237117012 Review Article REVIEW OF THE BASIC COMPONENTS OF CLINICAL PHARMACEUTICAL CARE IN PAKISTAN Taha Nazir, Syed Muzzammil Masood Zaidi School of Pharmacy, The University of Lahore, Islamabad Campus, 24-West, Jinnah Avenue, Blue Area, Islamabad, Pakistan. ABSTRACT Poor clinical pharmaceutical system in developing part of the world is big health hurdle. That also is a major reason of drug interactions, wrong medications, clinical errors, medical mistakes and therapeutical complications. We have aimed to uplift the health standards to mitigate drug abuse, enhance rational prescriptions and minimize the causalities. While going through the pharmaceutical care, we can’t ignore the channel through which the drugs supplied without proper check i.e. bio-safety, therapeutical monitoring, medication review etc. Moreover; something is missing in between the physician and patient to make sure the correct medication. The medial practice needs more legal and principled restrictions to assure the safe and correct therapy plans. The clinical legislation and drug rules of health practice seriously need the attention of judiciary, society and leadership to assure the safety of precious human live. Key words: clinical services, pharmaceutical care, primary health care, tertiary health care Corresponding Address: Dr. Taha Nazir, Associate Dean, School of Pharmacy, The University of Lahore, Islamabad Campus, 24-West, Jinnah Avenue, Blue Area, Islamabad, Pakistan. Cell: +92 321 222 0885, Tel.: 051-282 9162-64, Fax: 051-282 9238, Email: tahanazir@yahoo.com, www.uol.edu.pk There are eight (8) basic components of clinical pharmacy practice; Prescribing drugs, Administering drugs, Documenting professional services, Reviewing drug use, Communication, Counseling, Consulting and Preventing Medication Errors (Betty, 2010). While the scope of clinical pharmacy comprised of: Drug Information, Drug Utilization, Drug Evaluation and Selection, Medication Therapy Management, Formal Education and Training Program, Disease State Management and Application of Electronic Data Processing (EDP). The major segments of this discipline are; pharamcovigilance, pharmaco-economics, therapeutical monitoring, bio-safety, drug informations, and aseptic dispensary. Health care providers are negligent if they fail to provide the standard of care that a reasonable expert supposed to give in similar circumstances. If the negligence causes injuries or illness, then the health care provider is liable. There is no excuse to say: “I did my best, I just didn’t know any better”. If he know better, he is liable. If the doctor is clearly wrong, patient can sue for malpractice (CBA, 2010). Healthcare professionals are required to stay current in their knowledge of treatment methods and to meet a reasonable standard of care. According to medical malpractice law doctors have a duty to conduct their practice in accordance with the conduct of a prudent and diligent physician in the same circumstances (Medical Malpractice, 2010). Standards and regulations for medical malpractice vary by country and jurisdiction within countries. Medical professionals are required to maintain professional liability insurance
  • 3. T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011 2 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969, Fax: 924237117012 to offset the risk and costs of lawsuits based on local medical malpractice (The Four Elements of Medical Malpractice, (1997). World Health System Resources; Number of physicians and pharmacists vs population and hospital beds Country Physician Pharmaceutical personnel Hospital beds A Number Density A Number Density A Pakistan 126 350 8 8 102 <1 12 Bangladesh 42 881 3 9 411 <1 3 Bosnia and Herzegovina 5 540 14 308 <1 30 Fiji 380 5 90 1 21 Malaysia 17 020 7 2 880 1 19 Mexico 195 897 20 3 189 <1 10 Nepal 5 384 2 358 <1 2 Romania 41 455 19 901 <1 65 Russian Federation 614 183 43 11 521 <1 <1 97 Sri Lanka 10 479 6 990 <1 29 Sudan 11 083 3 1 531 <1 7 Swaziland 171 2 70 <1 Syrian Arab Republic 10 342 5 89 <1 14 United States of America 730 801 26 249 642 9 39 United Kingdom 133 641 23i 29 726 5 32 Yemen 44 960 6 24 080 3 39 Zambia 1 264 1 1 039 1 32 Global 8 413 147 13 2 338950 4 30 A per 10 000 Population (WHO, 2011) < Less than Thus; we have aimed to point out the professional negligencies usually committed in developing countries. It’s not unenthusiastic critics, professional revenge or commercially biased outlook but an optimistic manuscript to encourage the implementation of standard clinical regulations in the developing parts of the world. We also have tried to interpret the professional aspects of therapeutical care and clinical services to steer clear the reasons of malpractice. We wish to establish a “check” through medication supplied for patient use. Therapeutical drug monitoring, bio-safety, prescription reviewing, clinical evaluation and pharmaceutical services carry their meanings in medical and pharmaceutical sciences. Definitely; we are missing someone important in between the physician and patient if we are not successful to correct medication usage. In another way, the serious outcomes clinical discrepancies insist us to explain the clinical issues and scientific reasons, permissible apprehension and professional concerns. The therapeutical requirements
  • 4. T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011 3 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969, Fax: 924237117012 are not been fulfilled throughout the Pakistan (with the exception of Shaukat Khanum Cancer Hospital & Research Centre and Agha Khan Hospital). Scientifically the prescription is considered as health-care program to implement and governs the plan of care for an individual patient (Belknap et. al., 2008). The procedure of prescription and dispensing is used to avoid ambiguities or misinterpretation in clinical practice (Teichman & Caffee, 2002). The probability of wrong medication can be reduced if the prescription are be reviewed properly, the clinical plan evaluated correctly and pharmaceutical services provided with all of their formalities. Particularly, the drugs are not in control of qualified pharmacists. The community pharmacy practice does not follow the proper procedure. The information of patient, physician and drugs not properly collected and maintained during dispensing process. Especially the patient’s data i.e. medical history, social background, personal profile etc is much important to understand and manipulate to assure rational drug usage. Health Facilities in Pakistan 2006-07 Type Number Hospitals 965 Dispensaries 4,916 Basic Health Units 4,872 Rural Health Centers 595 Maternity care hospitals 1,138 TB Centers 371 First Aid Centers 1,080 Beds in hospitals & dispensaries 105,005 Population ion per bed 1,515 Population to health facility ratio 11,413 Source; Ministry of Health Utilization of Health Facilities of public and private sectors 2004-05 Type In percent Overall Rural Urban Private sector (total) 77.25 75.48 79.02 Dispensaries/; hospital 67.91 64.31 71.50 Hakeem/ Herbalist 2.04 2.32 1.76 Homeopathic 1.07 0.60 1.54 Chemist/ pharmacy 4.99 6.89 3.10 Siana/ Siani 1.19 1.36 1.01 Public Sector 22.58 24.18 20.99 Dispensary/ hospital 20.57 20.68 20.47 RHC/ BHC 2.01 3.50 0.52 Note: definition used: Number of sick or injured persons who consulted public versus private facilities/ providers for treatment, expressed as percentage of the total population that fell sick or was injured during the last 2 weeks before the PSLM interview. Source: Government of Pakistan, PSLM survey, 2004-05. Federal Bureau of Statistics Division, 2005. Therapeutic drug monitoring is an effective safety valve in clinical practice. The blood levels of potent drugs with a narrow therapeutic index are measured periodically to assure the safety of patients life (Marshall & Bangert, 2008). The health care workers are supposed to provide necessary arrangements of therapeutical drug monitoring in special cases. Pharmacovigilance is another useful constraint to minimize the therapeutical complications. It is applied for the purpose of detection, assessment, understanding and prevention of adverse effects of medicines (WHO, 2002). ADRs (adverse drug reactions) are the noxious and unintended effects which may occurs at normal dose used for the prophylaxis, diagnosis or treatment of disease, or for the modification of physiological function (WHO, 1972).
  • 5. T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011 4 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969, Fax: 924237117012 The International Pharmaceutical Federation (2010) has emphasized the six major elements to contribute to an overall strategic thrust of the board of pharmacy practice in hospital pharmacy section (http://www.fip.org/hospital_pharmacy). The six elements; the partnership with patients, enhancing pharmacy practice, better financial models, evidence-based practices, assuring competency and sufficient workforce are designed with the collaboration of World Health Organization, UNESCO, World Health Professions Alliance, Regional Pharmaceutical Forums and All other partners (FIP, 2010). They have a key role to assure the safe clinical therapeutical practice. Disregarding the recommendation of such international organization by medical staff may become major reason of causalities. The patient’s critics, complaint, views or resentment are another important feature of therapeutical care. Which are the expressions of displeasure or grievance (Lee (2010). In the civil law, the complaint is the formal pleading that starts the lawsuit in the plaintiff sets of facts and makes a claim for damages. Often the patient complaints correlate positively with malpractice risk. In a study at Vanderbilt University School of Medicine; the researchers found a strong link between doctors with a high number of patient complaints and doctors with a high number of risk management events. The communication problems, humaneness, clinical care, billing, access, and availability are considered as unsolicited complaints while the adverse reactions, potential liability and actual lawsuits are management events complaints (Lee, 2010). The government officials, society and judiciary should have to consider the pharmaceutical services, drug rules, therapeutical drug monitoring, phramcovigilance, prescription review and clinical evaluation. The clinical setup of hospital pharmacy of third world countries need the bio-safety, drug informations, and aseptic dispensary as accomplished in the developed part of the world. We must have to build up awareness about the pharmaceutical services. We have to place a “check” between the physician and patient to make sure the correct medication, right dose, proper route in exact time. That will reduce the casualties occurred every day and everywhere because of the wrong medications. It needs a collective effort to change the policies, regulations and system to assure the safety of precious live of innocent patients. RECOMMENDATIONS 1 Make sure the availability of clinical pharmaceutical services round the clock. The pharmacist must have to collect the medical, social, personal and professional data of patient to figure out any possible potential of drug related health hazard. 2 Enforcement of drugs rules to assure the standard drug monitoring system including prescription review, dose calculation and therapeutical evaluation. 3 Instigation of procedure to uncover the patient’s complaints i.e. suggestion box, patient satisfaction surveys etc. The patient or guardian should be briefed about the illness, treatment protocol, and possible outcomes if professional ethics have not any restriction to do so. 4 Implementation of the six major contributing elements of hospital pharmacy section designed by international pharmaceutical federation (FIP) with the collaboration of World Health Organization, UNESCO, World Health Professions Alliance, Regional Pharmaceutical Forums and all other partners (http://www.fip.org/hospital_pharmacy). 5 A process should be developed for handling patient complaints; that will help to create a long- term effect of reducing malpractice risks. Most patients are willing to forgive occasional annoyances or disappointments if they perceive that medical professional and the office staff care about their needs and are trying to satisfy them. Therefore; the verbal, nonwritten policy and unofficial procedure could help to develop good values and understanding. 6 The physician should keep the patients well treated and happy. They should be vigilant about the inevitable complaints and how to tackle them. Furthermore; in staff meetings the problems and complaints should be discussed strictly. 7 Any kind of patient’s letter, phone call, e-mail or text message should be considered and arrange/ invite for free consultation. He should be replied promptly with an expression of taking good care of his case that will mitigate the grumbles and improve level of satisfaction.
  • 6. T. Res. J. 01(01): 01-05 (2011) Nazir & Zaidi, 2011 5 | 47-Tanzeem Manzil, Bahawalsher Raod, Mazung, Lahore, Pakistan. Cell: 923335272042, Tel.: 924238431969, Fax: 924237117012 8 The patient should be addressed directly in case of clinical grievance. The physicians have to involve him more seriously to assure the quality of care concerns. The bad result is not necessarily the result of any human failures/ error. 9 The physician should be investigated for his mistake. Threatens of lawsuit is an excellent reason of quality services. But he could be helped by insurance coverage. The insurer should be notified. Notice is a requirement of all policies and it may authorize a quick settlement. 10 The problems related to the irregular visit, nonprofessional behavior, inadequate diagnostic facilities and non healthy condition in the hospital setting can only be resolved by designing certain rules and regulations. 11 The conversation with the patient should be documented in the patient's chart. This may later become evidence of the statue of limitations. At the same time the conversation with insurer or lawyer should be filed separately to assure the rule of justice. REFERENCES 1. Belknap SM, Moore H, Lanzotti SA, Yarnold PR, Getz M, et al., (2008). Application of software design principles and debugging methods to an analgesia prescription reduces risk of severe injury from medical use of opioids". Clinical Pharmacology & Therapeutics 84 (3): 385–92. 2. Betty H. Dennis (2010). An overview of the clinical pharmacist practitioner in NC. North Carolina Association of Pharmacists | 109 Church St. | Chapel Hill, NC 27516, Phone: 919.967.2237 | Fax: 919.968.9430. http://www.ncpharmacists.org/displaycommon.cfm?an=13 3. CBA (2010), The Canadian Bar Association, British Colombia Branch, 10th Floor, 845 Cambie Street, Vancouver, BC V6B 5T3 http://www.cba.org/bc/public_media/health/420.aspx 4. Lee J. Johnson, Esq (2010), Malpractice Dangers in Patient Complaints, Attorney with Johnson & Associates, Mt. Kisco, New York, Medscape, LLC, 370 Seventh Avenue, Suite 1101, New York, NY 10001-3967http://www.medscape.com/viewarticle/725001?src=mp&spon=17&uac=145767CJ 5. Marshall WJ, Bangert SK. (2008) Clinical Chemistry, 6th Edition. Edinburgh, London: Mosby Elsevier. 6. Medical Malpractice (2010) http://www.lawmedmal.ca/medical_malpractice_law.htm 7. Teichman PG, Caffee AE (2002). "Prescription writing to maximize patient safety" Family Practice Management 9 (7): 27–30. PMID 12221761. http://www.aafp.org/fpm/2002/0700/p27.pdf. 8. The Four Elements of Medical Malpractice, (1997). Yale New Haven Medical Center: Issues in Risk Management. 1997. http://info.med.yale.edu/caim/risk/malpractice/malpractice_2.html 9. WHO (2002). The Importance of Pharmacovigilance, World Health Organization, Avenue Appia 20 1211 Geneva 27 Switzerland.